Estrogen receptor (ER) and progesterone receptor (PgR) in breast cancer of Indian women
This paper has been retracted.
Amit V Patil1, Rahul S Bhamre2, Rajeev Singhai3, Mukund B Tayade4, Vinayak W Patil3
1Department of General Surgery, Government Medical College, Miraj, Maharashtra, India; 2Department of General Surgery, DY Patil Hospital and Research Centre, Nerul, Navi Mumbai, India; 3Department of Biochemistry, Grant Medical College and Sir JJ Group of Hospitals Mumbai, India; 4Department of General Surgery, Grant Medical College and Sir JJ Group of Hospitals Mumbai, India
Objective: To determine the expressions and relationship between estrogen receptors (ERs) and progesterone receptors (PgRs) in breast cancer in Indian women.
Participants: Surgically removed breast cancer tissues were collected from Grant Medical College and Sir JJ Group of Hospitals, Mumbai, India, taking (n = 300) cases of infiltrating duct cancer of Indian women after radical mastectomy and lumpectomy; the age- and menopausal-related subgroups satisfied this requirement.
Measurements: Statistical significance was calculated by the likelihood ratio test; relative risk served to check for significant differences. Relapse-free interval probabilities were calculated according to Kaplan and Meier, with Cox–Mantel test comparing survival functions and P values.
Results: We observed that only in middle-aged postmenopausal patients bearing pT2 tumors were ER and PgR receptors shown to have a prognostic significance with the lowest tested cutoff value being 5 fmol/mg.
Conclusion: Immunohistochemistry analysis has been shown to be a prognostic factor for patients with breast cancer; the major aim of determining the ER receptor status is to assess predictive response to hormonal therapy.
Keywords: prognostic cancer tissue biomarkers, immunohistochemistry, hormone receptors, steroid receptors
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML]
Other articles by this author:
Patil V, Tayade M, Pingale S, Dalvi S, Rajekar R, Deshmukh H, Patil S, Singhai R
Published Date: 11 August 2011
Singhai R, Patil VW, Patil AV
Published Date: 29 March 2011
Vinayak W Patil, Rajeev Singhai, Amit V Patil, et al
Published Date: 16 March 2011
Readers of this article also read:
Evaluation of glycine-bearing celecoxib derivatives as a colon-specific mutual prodrug acting on nuclear factor-κB, an anti-inflammatory target
Lee S, Lee Y, Kim W, Nam J, Jeong S, Yoo JW, Kim MS, Moon HR, Jung Y
Published Date: 7 August 2015
Godavarty A, Rodriguez S, Jung YJ, Gonzalez S
Published Date: 20 July 2015
Wang T, Diaz AJG, Yen Y
Published Date: 23 May 2014
PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysis
Liu YR, Jiang YZ, Zuo WJ, Yu KD, Shao ZM
Published Date: 10 April 2014
Chatterjee SJ, McCaffrey L
Published Date: 9 January 2014
Machairiotis N, Zarogoulidis P, Stylianaki A, Karatrasoglou E, Sotiropoulou G, Floreskou A, Chatzi E, Karamani A, Liapi G, Papakonstantinou E, Katsikogiannis N, Courcoutsakis N, Machairiotis C
Published Date: 8 March 2013
Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer
Bauer M, Bryce J, Hadji P
Published Date: 20 June 2012
Konoglou M, Porpodis K, Zarogoulidis P, Loridas N, Katsikogiannis N, Mitrakas A, Zervas V, Kontakiotis T, Papakosta D, Boglou P, Bakali S, Courcoutsakis N, Zarogoulidis K
Published Date: 11 January 2012
Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
Takeo Isozaki, Michihito Sato, Ryo Takahashi, et al
Published Date: 6 July 2010
Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device
Bliss Kaneshiro, Tod Aeby
Published Date: 1 July 2010